BioSpace News Archive

Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer promoting cellular micro-environment, today announces its expansion, with the incorporation if a U.S. subsidiary, Pleco Therapeutics USA, Inc., alongside the appointment of Michael Stalhamer as its President and first employee.

Justin Zenanko, CEO of SynerFuse, Inc., a Minneapolis-based medical device company, is pleased to announce completion last week of the company’s groundbreaking procedure in a fifth patient in the company’s proof-of-concept study.

LumiThera Inc., a commercial stage medical device company offering photobiomodulation treatment for ocular damage and disease, announced the purchase of MacuLogix assets by its wholly owned subsidiary.

Select Medical announced four of its inpatient rehabilitation hospitals have been recognized by U.S. News & World Report as Best Hospitals for rehabilitation in the country.

Forecast to 2030,’ thoroughly examines the Tonsillitis industry to provide essential data & information for the targeted readers.

Migraine treatments are intended to stop the symptoms or for preventing future attacks on the patients.

According to the most recent analysis by Emergen Research, the global market for anticonvulsants was valued at USD 18.16 billion in 2021 and is predicted to grow at a rate of 2.3 percent in terms of revenue during the forecast period.

According to the most recent report by Emergen Research, the worldwide Contract Research Organization (CRO) market size was USD 61.21 billion in 2021 and is anticipated to experience a revenue CAGR of 10.8 percent over the projected period.

The Alliance for Regenerative Medicine and the National Institute for Innovation in Manufacturing BioPharmaceuticals released Project A-Cell, a multistakeholder collaboration to incorporate Quality by Design principles into a manufacturing case study of a Chimeric Antigen Receptor T-cell therapy.

Vascular Dynamics, Inc. announced that the endovascular baroreflex amplification procedure using its MobiusHD device to treat patients with heart failure was featured during last month’s CSI Frankfurt 2022 25th anniversary Congress.